{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:55:05Z","timestamp":1787316905751,"version":"build-2736575974"},"reference-count":70,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Dialogues in Clinical Neuroscience"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/19585969.2023.2262464","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T10:42:58Z","timestamp":1696502578000},"page":"92-100","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-6094","authenticated-orcid":false,"given":"Sara V","family":"Carlini","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Maimonides Medical Center, Brooklyn, NY, USA"},{"name":"Downstate Health Sciences University, The State University of New York, Brooklyn, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0979-7901","authenticated-orcid":false,"given":"Lauren M","family":"Osborne","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics &amp; Gynecology and of Psychiatry, Weill Cornell Medicine, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-2236","authenticated-orcid":false,"given":"Kristina M","family":"Deligiannidis","sequence":"additional","affiliation":[{"name":"The Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA"},{"name":"Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Hempstead, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2020.0350"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104473"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13634"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.924"},{"key":"e_1_3_4_7_1","unstructured":"Brii Biosciences Limited 2023a. A Study of BRII-297 in healthy adult subjects. National Library of Medicine (US); [accessed 2023 May 23]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05845840."},{"key":"e_1_3_4_8_1","unstructured":"Brii Biosciences Limited 2023b. Brii Biosciences announces top-line results from phase 1 study of BRII-296 A long-acting therapy in development for postpartum depression. PRNewswire; [updated 26 Sep 2022; accessed 2023 23 May]. https:\/\/www.prnewswire.com\/news-releases\/brii-biosciences-announces-top-line-results-from-phase-1-study-of-brii-296-a-long-acting-therapy-in-development-for-postpartum-depression-301632804.html."},{"issue":"2","key":"e_1_3_4_9_1","first-page":"CD013560","article-title":"Antidepressant treatment for postnatal depression","volume":"2","author":"Brown JVE","year":"2021","unstructured":"Brown JVE, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E, Trevillion K, Howard LM, Khalifeh H. 2021. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2(2):CD013560.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_10_1","volume-title":"An open-label study to evaluate concentrations of Zuranolone in the Breast Milk of Healthy Lactating Women. 9th World Congress on Women\u2019s Mental Health","author":"Bullock A","year":"2022","unstructured":"Bullock A, Nandy I, Garcia M, Deligiannidis K, Wald J. 2022. An open-label study to evaluate concentrations of Zuranolone in the Breast Milk of Healthy Lactating Women. 9th World Congress on Women\u2019s Mental Health; November 6\u20139, 2022; Maastricht, Netherlands [Scientific poster presentation at the world congress on women' mental health]."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12042"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108035"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/2325957413495564"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v62n0803"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/jclp.20432"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867330666230320123952"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2016.05.010"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104827"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.1559"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20220785"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001690.pub2"},{"key":"e_1_3_4_22_1","unstructured":"Drugs and Lactation Database (LactMed\u00ae) 2006. National Institute of Child Health and Human Development."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620030-00002"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2022.09.143"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.10.016"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058981"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0166-4328(01)00170-x"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-023-00372-4"},{"key":"e_1_3_4_29_1","unstructured":"Gerbera Therapeutics Inc 2023. Nora 520. https:\/\/www.gerberarx.com\/en\/product\/detail\/NORA520. [accessed 2023 May 23]."},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)91414-2"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/24705470211020446"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1159\/000358838"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2017.06.008"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(98)71355-6"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31264-3"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hug.2576"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039488.2021.1974556"},{"key":"e_1_3_4_38_1","volume-title":"Saving Lives, Improving Mothers\u2019 Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2017-19","author":"Knight M","year":"2021","unstructured":"Knight M, Bunch K, Tuffnell D, Patel R, Shakespeare J, Kotnis R, Kenyon S, Kurinczuk J. 2021. Saving Lives, Improving Mothers\u2019 Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2017-19. Oxford: National Perinatal Epidemiology Unit, University of Oxford."},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb09940.x"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-019-00991-3"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.16121"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64239-4.00005-9"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.06.019"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.06.019"},{"key":"e_1_3_4_45_1","unstructured":"Marinus Pharmaceuticals 2019. Marinus pharmaceuticals announces data from Magnolia and Amaryllis Phase 2 studies in women with postpartum depression. [accessed 2023 May 23]. https:\/\/www.globenewswire.com\/news-release\/2019\/07\/23\/1886335\/0\/en\/Marinus-Pharmaceuticals-Announces-Data-from-Magnolia-and-Amaryllis-Phase-2-Studies-in-Women-with-Postpartum-Depression.html."},{"key":"e_1_3_4_46_1","unstructured":"Marinus Pharmaceuticals 2023a. A clinical trial of intravenous (IV) ganaxolone in women with postpartum depression. National Library of Medicine (S); [updated Feb 8; accessed 2023 1 June]. https:\/\/clinicaltrials.gov\/study\/NCT03228394."},{"key":"e_1_3_4_47_1","unstructured":"Marinus Pharmaceuticals 2023b. A clinical trial of oral ganaxolone in women with postpartum depression. National Library of Medicine (US); [updated 30 Jan 2023; accessed 2023 1 June]. https:\/\/clinicaltrials.gov\/study\/NCT03460756."},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00846"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-018-0937-4"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31551-4"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125316656297"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145705005079"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2019.01033"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2017.02.012"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2021.08.001"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2018.12.001"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000157"},{"key":"e_1_3_4_58_1","unstructured":"Sage Therapeutics 2023. A study to assess the safe-use conditions for administration of ZULRESSO\u00ae in a home setting. National Library of medicine (US); [accessed 2023 June 1]. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05059600."},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000650"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-016-0937-5"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2015-101334"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/1745506519844044"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040520"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-005-0071-2"},{"key":"e_1_3_4_65_1","volume-title":"Centers for Disease Control and Prevention US Department of Health and Human Services","author":"mTrost S","year":"2022","unstructured":"mTrost S, Beauregard J, Chandra G, Njie F, Berry J, Harvey A, Goodman D. 2022. Pregnancy-related deaths: data from maternal mortality review committees in 36\u2009US States, 2017\u20132019. Atlanta, GA: Centers for Disease Control and Prevention US Department of Health and Human Services."},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-022-01155-w"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000227706.56870.dd"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000351"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-009-0119-9"},{"key":"e_1_3_4_70_1","unstructured":"ZULRESSO Prescribing Information 2022. Cambridge MA: Sage Therapeutics Inc."},{"key":"e_1_3_4_71_1","unstructured":"ZURZUVAE Prescribing Information 2023. Cambridge MA: Biogen Inc. and Sage Therapeutics Inc."}],"container-title":["Dialogues in Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/19585969.2023.2262464","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T13:35:20Z","timestamp":1702474520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/19585969.2023.2262464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/19585969.2023.2262464"],"URL":"https:\/\/doi.org\/10.1080\/19585969.2023.2262464","relation":{},"ISSN":["1958-5969"],"issn-type":[{"value":"1958-5969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tdcn20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=tdcn20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}